179 related articles for article (PubMed ID: 10612019)
21. Preparation, Physicochemical Characterization and In Vitro and In Vivo Activity Against Heligmosomoides polygyrus of Novel Oral Formulations of Albendazole and Mebendazole.
Buchter V; Priotti J; Leonardi D; Lamas MC; Keiser J
J Pharm Sci; 2020 May; 109(5):1819-1826. PubMed ID: 32070702
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
Zhou Q; Wei X; Dou W; Chou G; Wang Z
Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
[TBL] [Abstract][Full Text] [Related]
23. The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.
Ding Y; Zhang Z; Ding C; Xu S; Xu Z
Molecules; 2023 Oct; 28(21):. PubMed ID: 37959715
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
25. Hot liquid extrusion assisted drug-cyclodextrin complexation: a novel continuous manufacturing method for solubility and bioavailability enhancement of drugs.
Manne ASN; Hegde AR; Raut SY; Rao RR; Kulkarni VI; Mutalik S
Drug Deliv Transl Res; 2021 Jun; 11(3):1273-1287. PubMed ID: 32959332
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
27. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
Veiga F; Fernandes C; Maincent P
Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
29. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
Cerchiara T; Luppi B; Bigucci F; Zecchi V
Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
Vlachou M; Papaïoannou G
J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
[TBL] [Abstract][Full Text] [Related]
32. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F
Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222
[TBL] [Abstract][Full Text] [Related]
33. Albendazole nanocrystals with improved pharmacokinetic performance in mice.
Paredes AJ; Bruni SS; Allemandi D; Lanusse C; Palma SD
Ther Deliv; 2018 Feb; 9(2):89-97. PubMed ID: 29325510
[TBL] [Abstract][Full Text] [Related]
34. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
Jambhekar S; Casella R; Maher T
Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
[TBL] [Abstract][Full Text] [Related]
35. Promising applications in drug delivery systems of a novel β-cyclodextrin derivative obtained by green synthesis.
García A; Leonardi D; Lamas MC
Bioorg Med Chem Lett; 2016 Jan; 26(2):602-608. PubMed ID: 26642766
[TBL] [Abstract][Full Text] [Related]
36. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
37. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice.
Lopez-Garcia ML; Torrado-Duran S; Torrado-Duran J; Martínez-Fernández AR; Bolás-Fernández F
Int J Parasitol; 1997 Jul; 27(7):781-5. PubMed ID: 9279580
[TBL] [Abstract][Full Text] [Related]
38. Cyclodextrin, an efficient tool for trans-anethole encapsulation: chromatographic, spectroscopic, thermal and structural studies.
Kfoury M; Auezova L; Greige-Gerges H; Ruellan S; Fourmentin S
Food Chem; 2014 Dec; 164():454-61. PubMed ID: 24996357
[TBL] [Abstract][Full Text] [Related]
39. Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions.
Castro SG; Sanchez Bruni SF; Urbizu LP; Confalonieri A; Ceballos L; Lanusse CE; Allemandi DA; Palma SD
Pharm Dev Technol; 2013; 18(2):434-42. PubMed ID: 22670782
[TBL] [Abstract][Full Text] [Related]
40. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.
Pillai K; Akhter J; Morris DL
J Cancer; 2017; 8(6):913-923. PubMed ID: 28529602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
